Skip to content
2000
Volume 26, Issue 7
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

A range of heterocyclic compounds, including Isatin (oneH-indole-2, 3-dione) and its by-products, have been shown to represent potential unit blocks in the synthesis of potential medicinal agents. Numerous studies have been carried out on isatin, its synthesis, biological uses, and its chemical composition since when it was discovered. Functionally, these isatin-containing heterocycles have demonstrated antibacterial, antidiabetic, antiviral, antitubercular, and anticancer properties, among many others. and efficaciousness of several Isatin moieties has been assessed in recent years based on their antimicrobial qualities. Isatin has shown great promise as a flexible heterocycle in the realm of drug development in recent years. Many viruses have caused extensive epidemics during the last 50 years, which have had detrimental effects on social, economic, and health conditions. The current unprecedented SARS-CoV-2 epidemic necessitates intensive research into the development of potent antiviral medications. It has been shown that Isatin, a flexible heterocycle, has a great deal of potential for drug development. Appropriately functionalized Isatin compounds have shown noteworthy and extensive antiviral activities throughout the last fifty years. The goal of this study is to gather all known data on Isatin derivatives' antiviral activity, emphasizing their structure-activity correlations as well as research on mechanistic and molecular modelling. We think that the scientific community will find this review to be a useful tool in the development of more efficient and powerful antiviral treatments based on Isatin scaffolds.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdt/10.2174/0113894501352560250115054156
2025-01-28
2025-10-31

  • From This Site

    /content/journals/cdt/10.2174/0113894501352560250115054156
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SilvaB.V. Isatin, a versatile molecule: Studies in Brazil.J. Braz. Chem. Soc.20132470772010.5935/0103‑5053.20130089
     [Google Scholar]
  2. Mı̇shraP. Mı̇shraA. BaheA.K. RoyA. DasR. Synthesis of Isatin and its derivatives containing heterocyclic compounds.J Turk Chem Socie Sect A: Chem2021841089109810.18596/jotcsa.962260
     [Google Scholar]
  3. NathR. PathaniaS. GroverG. AkhtarM.J. Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship.J. Mol. Struct.2020122212890010.1016/j.molstruc.2020.128900
     [Google Scholar]
  4. AhmadG. SohailM. BilalM. N-heterocycles as promising antiviral agents: A comprehensive overview.Molecules20242910223210.3390/molecules29102232 38792094
     [Google Scholar]
  5. ShuV.A. EniD.B. Ntie-KangF. A survey of isatin hybrids and their biological properties.Mol. Divers.20242412410.1007/s11030‑024‑10883‑z 38833124
     [Google Scholar]
  6. ElsamanT. MohamedM.S. EltayibE.M. Isatin derivatives as broad-spectrum antiviral agents: The current landscape.Med. Chem. Res.202231224427310.1007/s00044‑021‑02832‑4 35039740
     [Google Scholar]
  7. ZhangX. XiaY. LiP. Discovery of cyperenoic acid as a potent and novel entry inhibitor of influenza A virus.Antiviral Res.202422310582210.1016/j.antiviral.2024.105822 38350497
     [Google Scholar]
  8. Ortega-PrietoA.M. Jimenez-GuardeñoJ.M. Interferon-stimulated genes and their antiviral activity against SARS-CoV-2.MBio2024159e02100e0212410.1128/mbio.02100‑24 39171921
     [Google Scholar]
  9. WeiT. YueyueL. QiaoyunS. Mechanism of cross-resistance to fusion inhibitors conferred by the K394R mutation in respiratory syncytial virus fusion protein.J. Virol.20219520e012052110.1128/JVI.01205‑21 34379500
     [Google Scholar]
  10. Ferraz de PaivaR.E. VieiraE.G. Rodrigues da SilvaD. WegermannC.A. Costa FerreiraA.M. Anticancer compounds based on isatin-derivatives: Strategies to ameliorate selectivity and efficiency.Front. Mol. Biosci.2021762727210.3389/fmolb.2020.627272 33614708
     [Google Scholar]
  11. AltamimiM. SyedS.A. TuzunB. AlhazaniM.R. AlnemerO. BariA. Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents.J. Enzyme Inhib. Med. Chem.2024391228854810.1080/14756366.2023.2288548 38073431
     [Google Scholar]
  12. ChekeR.S. PatilV.M. FirkeS.D. Therapeutic outcomes of isatin and its derivatives against multiple diseases: Recent developments in drug discovery.Pharmaceuticals202215327210.3390/ph15030272 35337070
     [Google Scholar]
  13. ZhangY.Z. DuH.Z. LiuH.L. HeQ.S. XuZ. Isatin dimers and their biological activities.Arch Pharm20203533190029910.1002/ardp.201900299 31985855
     [Google Scholar]
  14. SharmaA. BhardwajV. SinghS. Putative role of isatin derivatives synthesis and their biological applications: A review.Int. J. Pharm. Sci. Res.20231426782685
     [Google Scholar]
  15. KhanapureS. JagadaleM. BansodeP. ChoudhariP. RashinkarG. Anticancer activity of ruthenocenyl chalcones and their molecular docking studies.J. Mol. Struct.2018117314214710.1016/j.molstruc.2018.06.091
     [Google Scholar]
  16. WangR. YinX. ZhangY. YanW. Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids.Eur. J. Med. Chem.201815658058610.1016/j.ejmech.2018.07.025 30025351
     [Google Scholar]
  17. JarapulaR. GangarapuK. MandaS. RekulapallyS. Synthesis, in vivo anti-inflammatory activity, and molecular docking studies of new isatin derivatives.Int. J. Med. Chem.20162016218102710.1155/2016/2181027 27022484
     [Google Scholar]
  18. ObafemiC.A. AdegbiteO.B. FadareO.A. Tryptanthrin from microwave-assisted reduction of isatin using solid-state-supported sodium borohydride: DFT calculations, molecular docking and evaluation of its analgesic and anti-inflammatory activity.Heliyon202171e0575610.1016/j.heliyon.2020.e05756 33437886
     [Google Scholar]
  19. ChirraS. Rao JupallyV. Study of antimicrobial, analgesic and anticonvulsant activity of novel isatin derivatives.Asian J. Pharm. Clin. Res.2016956510.22159/ajpcr.2016.v9i5.11725
     [Google Scholar]
  20. SinN. VenablesB.L. CombrinkK.D. Respiratory syncytial virus fusion inhibitors. Part 7: Structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo.Bioorg. Med. Chem. Lett.200919164857486210.1016/j.bmcl.2009.06.030 19596574
     [Google Scholar]
  21. BalT.R. AnandB. YogeeswariP. SriramD. Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives.Bioorg. Med. Chem. Lett.200515204451445510.1016/j.bmcl.2005.07.046 16115762
     [Google Scholar]
  22. Muğlu H, Çavuş MS, Bakı-r T, Yakan H. Synthesis, characterization, quantum chemical calculations and antioxidant activity of new bis-isatin carbohydrazone and thiocarbohydrazone derivatives.J. Mol. Struct.2019119681982710.1016/j.molstruc.2019.07.002
     [Google Scholar]
  23. RajV. Review on CNS activity of isatin derivatives.Int. J. Curr. Pharm. Res.2012419
     [Google Scholar]
  24. GandhiP.V. BurandeS.R. ChardeM.S. ChakoleR.D. A review on isatin and its derivatives: Synthesis, reactions and applications.Int. J. Adv. Sci. Res.20211211110.55218/JASR.202112401
     [Google Scholar]
  25. SilvaJ.F.M. GardenS.J. PintoA.C. The chemistry of isatins: A review from 1975 to 1999.J. Braz. Chem. Soc.200112327332410.1590/S0103‑50532001000300002
     [Google Scholar]
  26. MakhloufM.M. AlburaihH.A. ShehataM.M. AdamM.S.S. MostafaM.M. El-DenglaweyA. Synthesis, physicochemical and optical characterizations of a new isatin hydrazone derivative and its ZnO-complex for potential energy conversion and storage applications.J. Phys. Chem. Solids202115110981710.1016/j.jpcs.2020.109817
     [Google Scholar]
  27. BonviciniF. LocatelliA. MorigiR. LeoniA. GentilomiG.A. Isatin Bis-Indole and Bis-Imidazothiazole hybrids: Synthesis and antimicrobial activity.Molecules20222718578110.3390/molecules27185781 36144518
     [Google Scholar]
  28. HoltS.J. PetrowV. 111. Carbazoles, carbolines, and related compounds. Part I. Quindoline derivatives.J. Chem. Soc.1947607-61160710.1039/jr9470000607
     [Google Scholar]
  29. HajareR.A. GaurkhedeR.M. ChincholeP.P. ChandewarA.V. WandhareA.S. KarkiS.S. Synthesis, structure and spectral charectarization of friedal craft n-benzylation of isatin and their novel schiff’s bases.Asian J. Res. Chem20092289291
     [Google Scholar]
  30. XuZ. ZhaoS.J. LvZ.S. Fluoroquinolone-isatin hybrids and their biological activities.Eur. J. Med. Chem.201916239640610.1016/j.ejmech.2018.11.032 30453247
     [Google Scholar]
  31. PandeyaS.N. SriramD. NathG. de ClercqE. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin and its derivatives with triazole.Arzneimittelforschung2000501555910.1007/s00044‑011‑9838‑3 10683717
     [Google Scholar]
  32. BhriguB. PathakD. SiddiquiN. AlamM.S. AhsanW. Search for biological active isatins: A short review.Int. J. Pharm. Sci. Drug Res.2010210.25004/IJPSDR.2010.020402
     [Google Scholar]
  33. PakravanP. KashanianS. KhodaeiM.M. HardingF.J. Biochemical and pharmacological characterization of isatin and its derivatives: From structure to activity.Pharmacol. Rep. 201365231333510.1016/S1734‑1140(13)71007‑7 23744416
     [Google Scholar]
  34. BariS. MandaS. UgaleV. JupallyV.R. AkenaV. Rational design and synthesis of benzothiazolo-isatins for antimicrobial and cytotoxic activities.Indi J. Chem.201554B3418429
     [Google Scholar]
  35. MathurG. NainS. Recent advancement in synthesis of isatin as anticonvulsant agents: A review.Med. Chem.2014441742710.4172/2161‑0444.1000173
     [Google Scholar]
  36. AmmarYA. Sh El-ShariefA.M. BelalA. Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.Eur. J. Med. Chem.201815691893210.1016/j.ejmech.2018.06.061 30096580
     [Google Scholar]
  37. TurkevichN.M. LymarO.F. Synthesis of isatin derivatives with possible antiviral or antimicrobial action.Pharm. Chem. J.19693314514610.1007/BF00762570
     [Google Scholar]
  38. ZareZ. ImanzadehG. SoltanzadehZ. Solvent-free synthesis of new 3' h-spiro [indole-3, 2'-[1, 3]] benzothiazole-2 (1h)-one derivatives using michael reaction.Lett. Org. Chem.20171434735210.2174/1570178614666170321125529
     [Google Scholar]
  39. SriramD. YogeeswariP. GopalG. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs.Eur. J. Med. Chem.200540121373137610.1016/j.ejmech.2005.07.006 16129516
     [Google Scholar]
  40. FloresM. PenaJ. García-GarcíaP. GarridoN. DiezD. Enantioselective organocatalytic reactions with isatin.Curr. Org. Chem.201317181957198510.2174/13852728113179990092
     [Google Scholar]
  41. GirijaK. JamunaB. Design and synthesis of some novel schiff’s base aryl imidazole derivatives, characterization, docking and study of their anti-microbial activity, res.J. Pharm. Technol.20158407
     [Google Scholar]
  42. BadawyM.A. Abdel-HadyS.A. Reaction of isatin with thiocarbohydrazide: A correction.Arch. Pharm. (Weinheim)1991324634935110.1002/ardp.19913240605 1763945
     [Google Scholar]
  43. PathakA. Arti GautamP.M. DasS. Isatin: A short review of their antimicrobial activities.Int. J. Curr. Microbiol. Appl. Sci.2022111617710.20546/ijcmas.2022.1101.009
     [Google Scholar]
  44. PandeyaS.N. SriramD. NathG. De ClercqE. Synthesis and antimicrobial activity of Schiff and Mannich bases of isatin and its derivatives with pyrimidine.Farmaco199954962462810.1016/S0014‑827X(99)00075‑0 10555264
     [Google Scholar]
  45. BasavarajaiahS.M. MruthyunjayaswamyB.H.M. Synthesis and anti-microbial activity of (Z)-4-(4-substituted-thiazol-2-yl)-1-(2-oxoindolin-3-ylidene) semicarbazide and its derivatives.Indian J. Chem.201049811171126
     [Google Scholar]
  46. Rajesh KumarM. Violet DhayabaranV. SudhapriyaN. ManikandanA. GideonD.A. AnnapooraniS. p-TSA.H2O mediated one-pot, multi-component synthesis of isatin derived imidazoles as dual-purpose drugs against inflammation and cancer.Bioorg. Chem.202010210404610.1016/j.bioorg.2020.104046 32688115
     [Google Scholar]
  47. AliS. AlamM. Potential antimicrobial agents-I: Structural modifications and antimicrobial activity of some isatin derivatives.Arch. Pharm. Res.199417213113310.1007/BF02974237 10319145
     [Google Scholar]
  48. PodichettyA.K. WagnerS. SchröerS. Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis.J. Med. Chem.200952113484349510.1021/jm8015014 19445513
     [Google Scholar]
  49. ShvekhgeimerM.G.A. Synthesis of heterocyclic compounds by the cyclization of isatin and its derivatives. (review)Chem. Heterocycl. Compd. 199632324927610.1007/BF01169241
     [Google Scholar]
  50. SinghU.K. PandeyaS.N. SinghA. SrivastavaB.K. PandeyM. Synthesis and antimicrobial activity of Schiff’s and N-Mannich bases of isatin and its derivatives with 4-amino-N-carbamimidoyl benzene sulfonamide.Int. J. Pharm. Sci. Drug Res.2010215115410.25004/IJPSDR.2010.020214
     [Google Scholar]
  51. Abdel MotyS.G. HusseinM.A. Abdel AzizS.A. Abou-SalimM.A. Design and synthesis of some substituted thiazolo[3,2-a]pyrimidine derivatives of potential biological activities.Saudi Pharm. J.201624211913210.1016/j.jsps.2013.12.016 27013904
     [Google Scholar]
  52. PrakashC.R. RajaS. SaravananG. Synthesis, analgesic, anti-inflammatory and in vitro antimicrobial studies of some novel schiff and mannich base of 5-substituted isatin derivatives.Int. J. Pharm. Pharm. Sci.20146160166
     [Google Scholar]
  53. UtrejaD. KaurK. DhillonN.K. PathakR.K. 3-Hydroxy-3-alkylindolin-2-ones: Regioselective synthesis, molecular docking and nematicidal studies against Meloidogyne incognita.J. Environ. Sci. Health B202257865766910.1080/03601234.2022.2097504 35930393
     [Google Scholar]
  54. ArshadM. JadoonM. IqbalZ. Synthesis, molecular structure, quantum mechanical studies and urease inhibition assay of two new isatin derived sulfonylhydrazides.J. Mol. Struct.20171133808910.1016/j.molstruc.2016.11.065
     [Google Scholar]
  55. KumarG. SinghN.P. KumarK. Recent advancement of synthesis of isatins as a versatile pharmacophore: A review.Drug Res. (Stuttg.)202171311512110.1055/a‑1238‑2639 33296925
     [Google Scholar]
  56. PradeepS.D. GopalakrishnanA.K. ManoharanD.K. SoumyaR.S. GopalanR.K. MohananP.V. Isatin derived novel Schiff bases: An efficient pharmacophore for versatile biological applications.J. Mol. Struct.2023127113412110.1016/j.molstruc.2022.134121
     [Google Scholar]
  57. LahariK. SundararajanR. Design and synthesis of novel isatin derivatives as potent analgesic, anti-inflammatory and antimicrobial agents.J. Chem. Sci.202013219410.1007/s12039‑020‑01795‑0
     [Google Scholar]
  58. ShakirT.H. Al-MudhafarM.M.J. Synthesis and preliminary antimicrobial evaluation of Schiff bases of N-benzyl isatin derivatives.Syst. Rev. Pharm.2020111950195510.31838/srp.2020.12.297
     [Google Scholar]
  59. MondalP. JanaS. BoseA. BanerjeeM. Synthesis and evaluation of 1,3 di-substituted schiff, mannich bases and spiro isatin derivatives.J. Young Pharm.20102216917210.4103/0975‑1483.63164 21264121
     [Google Scholar]
  60. SumiM. NevadithaN.T. Sindhu KumariB. Synthesis, spectroscopic investigation and bioactivities of metal complexes from curcuma longa derivative.Inorg. Chim. Acta202354912139710.1016/j.ica.2023.121397
     [Google Scholar]
  61. SadeghianZ. BayatM. Green synthesis of isatin-based compounds.Res. Chem. Intermed.202248103987401610.1007/s11164‑022‑04817‑3
     [Google Scholar]
  62. PandeyaS.N. Sriraм D. Synthesis and screening for antibacterial activity of schiff’s and mannich bases of isatin and its derivatives.Acta Pharmaceutica Turcica19984013338
     [Google Scholar]
  63. De Moraes GomesP.A.T. PenaL.J. LeiteA.C.L. Isatin derivatives and their antiviral properties against arboviruses: A review.Mini Rev. Med. Chem.2018191566210.2174/1389557518666180424093305 29692243
     [Google Scholar]
  64. CombrinkK.D. GulgezeH.B. ThuringJ.W. Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety.Bioorg. Med. Chem. Lett.200717174784479010.1016/j.bmcl.2007.06.065 17616396
     [Google Scholar]
  65. Cihan-Üstündağ G, Naesens L, Şatana D, Erköse-Genç G, Mataracı--Kara E, Çapan G. Design, synthesis, antitubercular and antiviral properties of new spirocyclic indole derivatives.Monatsh. Chem.201915081533154410.1007/s00706‑019‑02457‑9 32214484
     [Google Scholar]
  66. ZhangH.M. DaiH. HansonP.J. Antiviral activity of an isatin derivative via induction of PERK-Nrf2-mediated suppression of cap-independent translation.ACS Chem. Biol.2014941015102410.1021/cb400775z 24547890
     [Google Scholar]
  67. VarmaR.S. NoblesW.L. Antiviral, antibacterial, and antifungal activities of isatin N-Mannich bases.J. Pharm. Sci.197564588188210.1002/jps.2600640539 1151666
     [Google Scholar]
  68. Zgórniak-NowosielskaI. GatkiewiczA. Poteć Z. The antiviral activity of isatin beta-thiosemicarbazone derivatives on vaccinia virus infection in mice.Arch. Immunol. Ther. Exp.1976244597601 999472
     [Google Scholar]
  69. deOliveiraM.R.P. TorresJ.C. GardenS.J. Synthesis and antiviral evaluation of isatin ribonucleosides.Nucleosi Nucleot Nucl Acid20022111-1282583510.1081/NCN‑120016510
     [Google Scholar]
  70. SelvamP. MurgeshN. ChandramohanM. In vitro antiviral activity of some novel isatin derivatives against HCV and SARS-CoV viruses.Indian J. Pharm. Sci.2008701919410.4103/0250‑474X.40339 20390088
     [Google Scholar]
  71. AbbasS.Y. FaragA.A. AmmarY.A. AtreesA.A. MohamedA.F. El-HenawyA.A. Synthesis, characterization, and antiviral activity of novel fluorinated isatin derivatives.Monatsh. Chem.2013144111725173310.1007/s00706‑013‑1034‑3 32214479
     [Google Scholar]
  72. SelvamP. MurugeshN. ChandramohanM. SidwellR.W. WanderseeM.K. SmeeD.F. Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3h-indol-3-ylidene)amino]-n-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.Antivir. Chem. Chemother.200617526927410.1177/095632020601700504 17176631
     [Google Scholar]
  73. GangarapuK. MandaS. JallapallyA. Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents.Med. Chem. Res.20142321046105610.1007/s00044‑013‑0684‑3 32214764
     [Google Scholar]
  74. LiW. ZhaoS.J. GaoF. LvZ.S. TuJ.Y. XuZ. Synthesis and in vitro anti-tumor, anti-mycobacterial and anti-hiv activities of diethylene-glycol-tethered bis-isatin derivatives.ChemistrySelect2018336102501025410.1002/slct.201802185
     [Google Scholar]
  75. ZhanP. LiuX. LiZ. PannecouqueC. De ClercqE. Design strategies of novel NNRTIs to overcome drug resistance.Curr. Med. Chem.200916293903391710.2174/092986709789178019 19747133
     [Google Scholar]
  76. MeledduR. DistintoS. CoronaA. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.Eur. J. Med. Chem.20159345246010.1016/j.ejmech.2015.02.032 25728026
     [Google Scholar]
  77. CoronaA. MeledduR. EspositoF. Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: Mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6.PLoS One2016111e014722510.1371/journal.pone.0147225 26800261
     [Google Scholar]
  78. MeledduR. DistintoS. CoronaA. Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase.J. Enzyme Inhib. Med. Chem.201732113013610.1080/14756366.2016.1238366 27766892
     [Google Scholar]
  79. SagarS. LiuP.P. CooperL.T.Jr Myocarditis.Lancet2012379981773874710.1016/S0140‑6736(11)60648‑X 22185868
     [Google Scholar]
  80. SriramD. BalT.R. YogeeswariP. Synthesis, antiviral and antibacterial activities of isatin mannich bases.Med. Chem. Res.200514421122810.1007/s00044‑005‑0135‑x
     [Google Scholar]
  81. JiangT. KuhenK.L. WolffK. Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I.Bioorg. Med. Chem. Lett.20061682105210810.1016/j.bmcl.2006.01.073 16480865
     [Google Scholar]
  82. Manley-KingC.I. BerghJ.J. PetzerJ.P. Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues.Bioorg. Med. Chem.201119126127410.1016/j.bmc.2010.11.028 21134756
     [Google Scholar]
  83. DroebnerK. PleschkaS. LudwigS. PlanzO. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.Antiviral Res.201192219520310.1016/j.antiviral.2011.08.002 21854809
     [Google Scholar]
  84. KhanF.A. MaalikA. Advances in pharmacology of isatin and its derivatives: A review.Trop. J. Pharm. Res.201514101937194210.4314/tjpr.v14i10.28
     [Google Scholar]
  85. SelvamP. ChandramohanM. De ClercqE. WitvrouwM. PannecouqueC. Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives.Eur. J. Pharm. Sci.200114431331610.1016/S0928‑0987(01)00197‑X 11684405
     [Google Scholar]
  86. MishraP. KumarA. MamidiP. Inhibition of chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea (MBZM-N-IBT).Sci. Rep.2016612012210.1038/srep20122 26843462
     [Google Scholar]
  87. PandeyaS.N. SriramD. NathG. DeClercqE. Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide.Eur. J. Pharm. Sci.199991253110.1016/S0928‑0987(99)00038‑X 10493993
     [Google Scholar]
  88. BalT.R. AnandB. YogeeswariP. SriramD. Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives.Bioorg. Med. Chem. Lett.2005152044514455 https://www.sciencedirect.com/science/article/abs/pii/S0960894X05009297
     [Google Scholar]
  89. NeytsJ. ClercqE.D. Therapy and short-term prophylaxis of poxvirus infections: Historical background and perspectives.Antiviral Res.2003571-2253310.1016/S0166‑3542(02)00197‑3 12615300
     [Google Scholar]
  90. Organization WH. W.H. Organization, WHO: Ebola situation report.2016Available from: https://www.afro.who.int/health-topics/ebola-disease/situation-reports
    [Google Scholar]
  91. BanerjeeD. YogeeswariP. BhatP. ThomasA. SrividyaM. SriramD. Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection.Eur. J. Med. Chem.201146110612110.1016/j.ejmech.2010.10.020 21093117
     [Google Scholar]
  92. TeitzY. BarkoN. AbmmoffM. RonenD. Relationships between structure and antiretroviral activity of thiosemicarbazone derivatives.Chemotherapy199440319520010.1159/000239192 8205938
     [Google Scholar]
  93. SelvamP. ChandramohanM. HurstB.L. SmeeD.F. Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture.Antivir. Chem. Chemother.201020314314610.3851/IMP1471 20054101
     [Google Scholar]
  94. MotiwaleM. YadavN.S. KumarS. Finding potent inhibitors for COVID-19 main protease (M pro): An in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA.J. Biomol. Struct. Dyn.20224041534154510.1080/07391102.2020.1829501 33030102
     [Google Scholar]
  95. DevaleT.L. ParikhJ. MiniyarP. SharmaP. ShrivastavaB. MurumkarP. Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.Bioorg. Chem.20177025626610.1016/j.bioorg.2017.01.006 28160944
     [Google Scholar]
  96. ChenL.R. WangY.C. LinY.W. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.Bioorg. Med. Chem. Lett.200515123058306210.1016/j.bmcl.2005.04.027 15896959
     [Google Scholar]
  97. BadavathV.N. KumarA. SamantaP.K. Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (m pro): A molecular docking, molecular dynamics and structure-activity relationship studies.J. Biomol. Struct. Dyn.20224073110312810.1080/07391102.2020.1845800 33200681
     [Google Scholar]
  98. LiangP.H. Characterization and inhibition of SARS-coronavirus main protease.Curr. Top. Med. Chem.20066436137610.2174/156802606776287090 16611148
     [Google Scholar]
  99. PandeyaS.N. YogeeswariP. SriramD. de ClercqE. PannecouqueC. WitvrouwM. Synthesis and screening for anti-HIV activity of some N-Mannich bases of isatin derivatives.Chemotherapy199945319219610.1159/000007182 10224341
     [Google Scholar]
  100. KumarR. GideonD.A. MariadasseR. In silico evaluation of isatin-based derivatives with RNA-dependent RNA polymerase of the novel coronavirus SARS-CoV-2.J. Biomol. Struct. Dyn.202140156710672410.1080/07391102.2021.1890223 33615998
     [Google Scholar]
/content/journals/cdt/10.2174/0113894501352560250115054156
Loading
From Structure to Function: Isatin Derivatives as a Promising Class of Antiviral Agents
Curr Drug Targets 26, 470 (2025); https://doi.org/10.2174/0113894501352560250115054156
/content/journals/cdt/10.2174/0113894501352560250115054156
/content/journals/cdt/10.2174/0113894501352560250115054156
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): antiviral; Isatin; isatin hybrids; N-Mannich bases; SARS-CoV-2; structure activity relationship

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test